Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma

Toxicology and Applied Pharmacology

Volumn 272, Issue 1, 2013, Pages 30-36

  Wu, Chia Chang ^a,b   Huang, Yung Kai ^a   Chung, Chi Jung ^c,d   Huang, Chao Yuan ^e   Pu, Yeong Shiau ^e   Shiue, Horng Sheng ^f   Lai, Li An ^a   Lin, Ying Chin ^b,g   Su, Chien Tien ^h   Hsueh, Yu Mei ^a,i  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Arsenic methylation capacity; IL 8; TNF ; Urothelial carcinoma

Indexed keywords

ARSENIC; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; METHYLATION; PROMOTER REGION; RISK FACTOR; SMOKING; TRANSCRIPTION INITIATION; TRANSITIONAL CELL CARCINOMA; URINE LEVEL;

ARSENIC; ARSENIC METHYLATION CAPACITY; IL-8; TNF-Α; UROTHELIAL CARCINOMA;

AGED; ARSENICALS; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; METHYLATION; MIDDLE AGED; POLYMORPHISM, GENETIC; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK; SOCIOECONOMIC FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UROLOGIC NEOPLASMS;

EID: 84882772877     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.019     Document Type: Article

References (61)

1. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 2006, 72:1605-1621.
2. Ahirwar D., Kesarwani P., Manchanda P.K., Mandhani A., Mittal R.D. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guerin immunotherapy in bladder cancer. Cancer Genet. Cytogenet. 2008, 184:1-8.
3. Ahirwar D.K., Mandhani A., Dharaskar A., Kesarwani P., Mittal R.D. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy. BJU Int. 2009, 104:867-873.
4. Ahirwar D.K., Mandhani A., Mittal R.D. IL-8 -251 T>A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort. Arch. Med. Res. 2010, 41:97-103.
5. Ahuja S.K., Ozcelik T., Milatovitch A., Francke U., Murphy P.M. Molecular evolution of the human interleukin-8 receptor gene cluster. Nat. Genet. 1992, 2:31-36.
6. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006, 25:409-416.
7. Bunderson M., Brooks D.M., Walker D.L., Rosenfeld M.E., Coffin J.D., Beall H.D. Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol. Appl. Pharmacol. 2004, 201:32-39.
8. Chen C.J., Kuo T.L., Wu M.M. Arsenic and cancers. Lancet 1988, 1:414-415.
9. Chen Y.C., Su H.J., Guo Y.L., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003, 14:303-310.
10. Chen C.H., Chiou H.Y., Hsueh Y.M., Chen C.J., Yu H.J., Pu Y.S. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan. J. Urol. 2009, 181:547-552.
11. Chen C.L., Chiou H.Y., Hsu L.I., Hsueh Y.M., Wu M.M., Chen C.J. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environ. Res. 2010, 110:455-462.
12. Chikazawa M., Inoue K., Fukata S., Karashima T., Shuin T. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Pathobiology 2008, 75:335-345.
13. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153:411-418.
14. Chung C.J., Huang C.J., Pu Y.S., Su C.T., Huang Y.K., Chen Y.T., Hsueh Y.M. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area. Toxicol. Appl. Pharmacol. 2008, 226:14-21.
15. Das S., Santra A., Lahiri S., Guha Mazumder D.N. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol. Appl. Pharmacol. 2005, 204:18-26.
16. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 2002, 39:531-536.
17. Duarte I., Santos A., Sousa H., Catarino R., Pinto D., Matos A., Pereira D., Moutinho J., Canedo P., Machado J.C., Medeiros R. G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem. Biophys. Res. Commun. 2005, 334:588-592.
18. Escobar-Garcia D.M., Del Razo L.M., Sanchez-Pena L.C., Mandeville P.B., Lopez-Campos C., Escudero-Lourdes C. Association of glutathione S-transferase Omega 1-1 polymorphisms (A140D and E208K) with the expression of interleukin-8 (IL-8), transforming growth factor beta (TGF-beta), and apoptotic protease-activating factor 1 (Apaf-1) in humans chronically exposed to arsenic in drinking water. Arch. Toxicol. 2012, 86:857-868.
19. Escudero-Lourdes C., Medeiros M.K., Cardenas-Gonzalez M.C., Wnek S.M., Gandolfi J.A. Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model. Toxicol. Appl. Pharmacol. 2010, 244:162-173.
20. Escudero-Lourdes C., Wu T., Camarillo J.M., Gandolfi A.J. Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells. Toxicol. Appl. Pharmacol. 2012, 258:10-18.
21. Fernandez-Real J.M., Broch M., Vendrell J., Richart C., Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J. Clin. Endocrinol. Metab. 2000, 85:1334-1339.
22. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
23. Gao L.B., Pan X.M., Jia J., Liang W.B., Rao L., Xue H., Zhu Y., Li S.L., Lv M.L., Deng W., Chen T.Y., Wei Y.G., Zhang L. IL-8-251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur. J. Cancer 2010, 46:1333-1343.
24. Hopenhayn-Rich C., Biggs M.L., Fuchs A., Bergoglio R., Tello E.E., Nicolli H., Smith A.H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996, 7:117-124.
25. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456.
26. Hsueh Y.M., Huang Y.L., Huang C.C., Wu W.L., Chen H.M., Yang M.H., Lue L.C., Chen C.J. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ Health A 1998, 54:431-444.
27. Huang Y.K., Huang Y.L., Hsueh Y.M., Yang M.H., Wu M.M., Chen S.Y., Hsu L.I., Chen C.J. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 2008, 19:829-839.
28. Inoue K., Slaton J.W., Kim S.J., Perrotte P., Eve B.Y., Bar-Eli M., Radinsky R., Dinney C.P. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res. 2000, 60:2290-2299.
29. Jeong P., Kim E.J., Kim E.G., Byun S.S., Kim C.S., Kim W.J. Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression. Urology 2004, 64:1052-1056.
30. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
31. Kim E.J., Jeong P., Quan C., Kim J., Bae S.C., Yoon S.J., Kang J.W., Lee S.C., Jun W.J., Kim W.J. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 2005, 65:70-75.
32. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 1997, 34:391-399.
33. Lan C.C., Yu H.S., Ko Y.C. Chronic arsenic exposure and its adverse health effects in Taiwan: a paradigm for management of a global environmental problem. Kaohsiung J. Med. Sci. 2011, 27:411-416.
34. Lee W.P., Tai D.I., Lan K.H., Li A.F., Hsu H.C., Lin E.J., Lin Y.P., Sheu M.L., Li C.P., Chang F.Y., Chao Y., Yen S.H., Lee S.D. The -251 T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 2005, 11:6431-6441.
35. Leibovici D., Grossman H.B., Dinney C.P., Millikan R.E., Lerner S., Wang Y., Gu J., Dong Q., Wu X. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J. Clin. Oncol. 2005, 23:5746-5756.
36. Lin Y.J., Chen R.H., Wan L., Sheu J.C., Huang C.M., Lin C.W., Chen S.Y., Lai C.H., Lan Y.C., Hsueh K.C., Tsai C.H., Lin T.H., Huang Y.M., Chao K., Chen D.Y., Tsai F.J. Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients. Lupus 2009, 18:974-979.
37. Ma Y., Niu R., Sun Z., Wang J., Luo G., Zhang J., Wang J. Inflammatory responses induced by fluoride and arsenic at toxic concentration in rabbit aorta2. Arch. Toxicol. 2012, 86:849-856.
38. Marsh H.P., Haldar N.A., Bunce M., Marshall S.E., le M.K., Winsey S.L., Christodoulos K., Cranston D., Welsh K.I., Harris A.L. Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation. Br. J. Cancer 2003, 89:1096-1101.
39. Mo J., Xia Y., Wade T.J., DeMarini D.M., Davidson M., Mumford J. Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: assessment by real-time PCR arrays. Int. J Environ Res Public Health 2011, 8:2090-2108.
40. Nonomura N., Tokizane T., Nakayama M., Inoue H., Nishimura K., Muramatsu M., Okuyama A. Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients. Int. J. Urol. 2006, 13:971-976.
41. O'Brien T.S., Fox S.B., Dickinson A.J., Turley H., Westwood M., Moghaddam A., Gatter K.C., Bicknell R., Harris A.L. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res. 1996, 56:4799-4804.
42. Ohyauchi M., Imatani A., Yonechi M., Asano N., Miura A., Iijima K., Koike T., Sekine H., Ohara S., Shimosegawa T. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005, 54:330-335.
43. Otto K.B., Acharya S.S., Robinson V.L. Stress-activated kinase pathway alteration is a frequent event in bladder cancer. Urol. Oncol. 2012, 30:415-420.
44. Pelucchi C., Bosetti C., Negri E., Malvezzi M., La V.C. Mechanisms of disease: the epidemiology of bladder cancer. Nat. Clin. Pract. Urol. 2006, 3:327-340.
45. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Huang S.K., Chiu A.W., Yang M.H., Chen C.J., Hsueh Y.M. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol. Appl. Pharmacol. 2007, 218:99-106.
46. Shen C., Sun H., Sun D., Xu L., Zhang X., Liu A., Jia X., Bai J., Chen F., Yu Y., Jin Y., Yu J., Fu S. Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2011, 126:763-770.
47. Simeonova P.P., Hulderman T., Harki D., Luster M.I. Arsenic exposure accelerates atherogenesis in apolipoprotein E-/- mice. Environ. Health Perspect. 2003, 111:1744-1748.
48. Styblo M., Drobna Z., Jaspers I., Lin S., Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 2002, 110(Suppl. 5):767-771.
49. Taguchi A., Ohmiya N., Shirai K., Mabuchi N., Itoh A., Hirooka Y., Niwa Y., Goto H. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2487-2493.
50. Tezuka M., Hanioka K., Yamanaka K., Okada S. Gene damage induced in human alveolar type II (L-132) cells by exposure to dimethylarsinic acid. Biochem. Biophys. Res. Commun. 1993, 191:1178-1183.
51. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 2001, 176:127-144.
52. Tsai F.J., Lu H.F., Yeh L.S., Hsu C.D., Chen W.C. Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients. Urol. Res. 2001, 29:412-416.
53. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.
54. Vahter M., Concha G. Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 2001, 89:1-5.
55. Vairaktaris E., Yapijakis C., Serefoglou Z., Derka S., Vassiliou S., Nkenke E., Vylliotis A., Wiltfang J., Avgoustidis D., Critselis E., Neukam F.W., Patsouris E. The interleukin-8 (-251 A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur. J. Surg. Oncol. 2007, 33:504-507.
56. Wnek S.M., Kuhlman C.L., Camarillo J.M., Medeiros M.K., Liu K.J., Lau S.S., Gandolfi A.J. Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol. Appl. Pharmacol. 2011, 257:1-13.
57. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001, 12:375-391.
58. Xu B., Niu X.B., Wang Z.D., Cheng W., Tong N., Mi Y.Y., Min Z.C., Tao J., Li P.C., Zhang W., Wu H.F., Zhang Z.D., Wang Z.J., Hua L.X., Feng N.H., Wang X.R. IL-6 -174 G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol. Biol. Rep. 2011, 38:2589-2596.
59. Yang J.J., Ko K.P., Cho L.Y., Shin A., Gwack J., Chang S.H., Shin H.R., Yoo K.Y., Kang D., Park S.K. The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer 2009, 9:238.
60. Zhang Z., Wang X., Cheng S., Sun L., Son Y.O., Yao H., Li W., Budhraja A., Li L., Shelton B.J., Tucker T., Arnold S.M., Shi X. Reactive oxygen species mediate arsenic induced cell transformation and tumorigenesis through Wnt/beta-catenin pathway in human colorectal adenocarcinoma DLD1 cells. Toxicol. Appl. Pharmacol. 2011, 256:114-121.
61. Zhou P., Lv G.Q., Wang J.Z., Li C.W., Du L.F., Zhang C., Li J.P. The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS One 2011, 6:e22092.